18.97.14.84
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Trending Topics

FDA grants accelerated approval for early Alzheimer’s drug

The U.S. Food and Drug Administration has approved Leqembi (lecanemab-irmb) for the treatment of Alzheimer’s disease, according to a press release. Approval was granted via the Accelerated Approval pathway based on results from the phase 3 randomized, controlled clinical trial which confirmed the clinical benefit of lecanemab. In the double-blind,...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
Videos
30 Dec, 2022

-Advertisement-
-Advertisement-
-Advertisement-